ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
272.32
3.75
(1.40%)
Closed 12 April 6:00AM
272.00
-0.32
(-0.12%)
After Hours: 7:15AM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
185.000.000.000.000.000.000.00 %00-
190.0080.9084.1041.4082.500.000.00 %02-
195.000.000.000.000.000.000.00 %00-
200.000.000.000.000.000.000.00 %00-
210.0061.1064.3043.1062.700.000.00 %06-
220.000.000.000.000.000.000.00 %00-
230.0041.7044.9024.5043.300.000.00 %03-
240.000.000.000.000.000.000.00 %00-
250.000.000.000.000.000.000.00 %00-
260.000.000.000.000.000.000.00 %00-
270.000.000.000.000.000.000.00 %00-
280.000.000.000.000.000.000.00 %00-
290.000.654.001.852.325-0.23-11.06 %13912/4/2025
300.000.252.900.801.5750.000.00 %0402-
310.000.052.450.051.250.000.00 %025-
320.001.752.251.752.000.000.00 %0350-
330.000.000.000.000.000.000.00 %00-
340.001.782.151.781.9650.000.00 %03-
350.001.502.151.501.8250.000.00 %01-
360.000.000.000.000.000.000.00 %00-

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
185.000.002.150.000.000.000.00 %00-
190.000.000.000.000.000.000.00 %00-
195.000.000.000.000.000.000.00 %00-
200.000.000.000.000.000.000.00 %00-
210.000.000.000.000.000.000.00 %00-
220.000.052.5511.101.300.000.00 %07-
230.000.202.902.501.550.000.00 %09-
240.000.503.507.002.000.000.00 %05-
250.001.004.503.502.751.5075.00 %14812/4/2025
260.000.000.000.000.000.000.00 %00-
270.000.000.000.000.000.000.00 %00-
280.0010.1013.508.3011.800.000.00 %060-
290.000.000.000.000.000.000.00 %00-
300.0026.6031.1026.4028.858.2045.05 %1412/4/2025
310.0036.4040.3047.0038.350.000.00 %09-
320.0046.1049.800.0047.950.000.00 %00-
330.000.000.000.000.000.000.00 %00-
340.000.000.000.000.000.000.00 %00-
350.0076.0081.000.0078.500.000.00 %00-
360.000.000.000.000.000.000.00 %00-

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSPRMSP Recovery Inc
US$ 2.479
(93.67%)
87.38M
PRTGPortage Biotech Inc
US$ 8.5091
(66.85%)
31.29M
WTOUTime Limited
US$ 2.15
(61.65%)
1.19M
BFRGBullfrog AI Holdings Inc
US$ 2.09
(48.23%)
13.81M
THTXTheratechnologies Inc
US$ 1.94
(45.86%)
49.4M
TOROVToro Corporation
US$ 1.43
(-82.48%)
109.39k
LUCYInnovative Eyewear Inc
US$ 2.3471
(-52.58%)
1.98M
XHGXChange TED Inc
US$ 0.1985
(-45.71%)
8.7M
MULNMullen Automotive Inc
US$ 2.18
(-39.44%)
4.35M
FLDFold Holdings Inc
US$ 2.6601
(-33.50%)
1.74M
DMNDamon Inc
US$ 0.003
(-28.57%)
1.08B
BONBon Natural Life Ltd
US$ 0.066
(8.73%)
658M
STSSSharps Technology Inc
US$ 0.0245
(33.88%)
653.02M
NVDANVIDIA Corporation
US$ 110.93
(3.12%)
313.46M
LGMKLogicMark Inc
US$ 0.009699
(3.18%)
264.71M

PEN Discussion

View Posts
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 4 years ago
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 10 years ago
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 10 years ago
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 10 years ago
IPO should be out soon.
no symbol yet.
👍️0